Evidence map›Paper›PMID 26541470›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2016

Changes in the NMR Metabolic Profile of Live Human Neuron-Like SH-SY5Y Cells Exposed to Interferon-α2.

Righi Valeria, Schenetti Luisa, Mucci Adele, Benatti Stefania, Tascedda Fabio, Brunello Nicoletta, Pariante M Carmine, Alboni Silvia

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Live Metabolomics with NMR.Analytical chemistry · 2026
    Review
  2. Article
  3. Type 1-type 2 interferon imbalance in dry eye disease.Indian journal of ophthalmology · 2023
    Observational
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Righi ValeriaDepartment for Life Quality Studies, University of Bologna, Rimini, Italy.
Schenetti LuisaDepartment of Life Sciences, University of Modena and Reggio Emilia, via G. Campi, 287, 41125, Modena, Italy.
Mucci AdeleDepartment of Chemical and Geological Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Benatti StefaniaDepartment of Life Sciences, University of Modena and Reggio Emilia, via G. Campi, 287, 41125, Modena, Italy.
Tascedda FabioDepartment of Life Sciences, University of Modena and Reggio Emilia, via G. Campi, 287, 41125, Modena, Italy.
Brunello NicolettaDepartment of Life Sciences, University of Modena and Reggio Emilia, via G. Campi, 287, 41125, Modena, Italy.
Pariante M CarmineStress, Psychiatry and Immunology Department of Psychological Medicine Institute of Psychiatry, Kings College London, London, UK.
Alboni SilviaDepartment of Life Sciences, University of Modena and Reggio Emilia, via G. Campi, 287, 41125, Modena, Italy. silvia.alboni@unimore.it.
University of Modena and Reggio Emilia · ITKing's College London · GBUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon (IFN)-α2 is an extensively therapeutically used pro-inflammatory cytokine. Though its efficacy in controlling viral replication and tumor cells proliferation, administration of IFN-α2 is often associated with the development of central side effects. Magnetic resonance spectroscopy studies have demonstrated that IFN-α2 administration affects brain metabolism, however the exact nature of this effect is not completely known. We hypothesized that IFN-α2 can affect metabolic activity of human neuron-like SH-SY5Y cells which possess many characteristics of neurons and represent one of the most used models for studying mechanisms involved in neurotoxicity or neuroprotection. To test our hypothesis we have characterized the metabolic signature of live SH-SY5Y, and their conditioned media, after 24 and 72 h of exposure to vehicle or IFN-α2 (100 ng/ml) by using High Resolution-Magic Angle Spinning (HR-MAS) Nuclear Magnetic Resonance (NMR) spectroscopy. Our results revealed that 1) the use of HR-MAS NMR is ideally suitable for the characterization of the metabolic profile of live cells and their conditioned media without extraction procedures; and 2) a 72 h exposure to IFN-α2 increases the level of metabolites involved in maintaining energetic (including creatine and lactate) and osmotic (such as myo-inositol, scyllo-inositol, taurine and glycerophosphorylcholine) balances in neuron-like cells and of metabolic waste products (namely lactate, ethanol and acetate), glycine and glutamine in their growth media. These results may contribute to gain more knowledge about the IFN-α2 induced effect on the brain and support the interpretation of magnetic resonance spectroscopy studies performed in humans.

Indexed as

Cell LineCell SurvivalCulture Media, ConditionedHumansInterferon-alphaMagnetic Resonance SpectroscopyMetabolomeNeuronsCulture Media, ConditionedInterferon-alphaHR-MAS NMRIFN-αMetabolomicsNeurotoxicityOsmolytesSH-SY5Y cells

Identifiers

PMID26541470
OpenAlexW2193109575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.